102 related articles for article (PubMed ID: 3906590)
1. Multiple cleavage sites of cholecystokinin heptapeptide by "enkephalinase".
Durieux C; Charpentier B; Fellion E; Gacel G; Pelaprat D; Roques BP
Peptides; 1985; 6(3):495-501. PubMed ID: 3906590
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the metabolism of CCK8 analogues by rat brain slices.
Durieux C; Charpentier B; Pelaprat D; Roques BP
Neuropeptides; 1986 Jan; 7(1):1-9. PubMed ID: 3456492
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
5. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
Deschodt-Lanckman M; Strosberg AD
FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
[TBL] [Abstract][Full Text] [Related]
6. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
Charpentier B; Durieux C; Menant I; Roques BP
J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
[TBL] [Abstract][Full Text] [Related]
7. [3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.
Pélaprat D; Zajac JM; Gacel G; Durieux C; Morgat JL; Sasaki A; Roques BP
Life Sci; 1985 Dec; 37(26):2483-90. PubMed ID: 3001463
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
Najdovski T; Collette N; Deschodt-Lanckman M
Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
[TBL] [Abstract][Full Text] [Related]
9. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
12. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides.
Gafford JT; Skidgel RA; Erdös EG; Hersh LB
Biochemistry; 1983 Jun; 22(13):3265-71. PubMed ID: 6349683
[TBL] [Abstract][Full Text] [Related]
13. Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.
Deschodt-Lanckman M; Bui ND; Noyer M; Christophe J
Regul Pept; 1981 Apr; 2(1):15-30. PubMed ID: 6262880
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue.
Ruiz-Gayo M; Daugé V; Menant I; Bégué D; Gacel G; Roques BP
Peptides; 1985; 6(3):415-20. PubMed ID: 2415950
[TBL] [Abstract][Full Text] [Related]
15. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
Su SF; Amidon GL; Lee HJ
Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
[TBL] [Abstract][Full Text] [Related]
16. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
[TBL] [Abstract][Full Text] [Related]
19. 1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: influence of the sulfate group on the peptide folding.
Durieux C; Belleney J; Lallemand JY; Roques BP; Fournie-Zaluski MC
Biochem Biophys Res Commun; 1983 Jul; 114(2):705-12. PubMed ID: 6882451
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.
Böhme GA; Durieux C; Stutzmann JM; Charpentier B; Roques BP; Blanchard JC
Peptides; 1989; 10(2):407-14. PubMed ID: 2755879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
